Key result
Positive pre-operative ischemia testing is linked to ~160% higher 3-month cardiovascular risk post-kidney transplant.
Why the study?
Renal transplant patients have a high peri-operative risk for cardiovascular events, and while pre-operative screening for cardiac ischaemia might lower this risk, specific guidelines are lacking.
Cohort (n=770)
No
Relative Risk: 2.6 (95% CI 1.4–5.1)
Absolute Event Rate: 24% vs 6%
p-value: p=0.01
Pre-transplant cardiac history, older age, positive non-invasive ischemia testing, and post-operative anemia are significant predictors of cardiovascular complications within 3 months after kidney transplantation.
High peri-operative CV risk persists despite screening; leaves open whether refined protocols improve outcomes in renal transplant candidates.
BACKGROUND: Renal transplant patients have a high peri-operative risk for cardiovascular events. Pre-operative screening for cardiac ischaemia might lower this risk, but there are no specific guidelines. METHODS: We conducted a chart review for all renal transplants performed between January 2010 and December 2013. We collected data about patient characteristics, pre-operative cardiac evaluation before referral, diagnostic tests and interventions. Logistic regression analyses were then applied to relate these factors to the composite endpoint of cardiac death, myocardial infarction, coronary revascularisation or admission for heart failure within 3 months after transplantation. RESULTS: A total of 770 kidney transplants were performed in 751 patients. In 750 cases (97%) a referral to the cardiologist was made. Non-invasive ischaemia detection by myocardial perfusion scintigraphy, exercise stress test or dobutamine stress echocardiography was carried out in 631 cases (82%). Coronary angiography was performed in 85 cases, which revealed significant coronary artery disease in 19 cases. Prophylactic revascularisation was done in 7 cases. The incidence of the study endpoint was 8.6%. In multivariable regression analysis, age at transplantation, pre-transplant myocardial infarction or heart failure, post-operative decrease in haemoglobin and positive non-invasive ischaemia testing were significantly associated with the study endpoint. However, when analysed separately, none of the different non-invasive ischaemia detection modalities were related to the study endpoint. CONCLUSION: Especially those renal transplant candidates with a cardiac history carry a high risk for a cardiovascular event post-transplantation. Uniformity in cardiac screening of renal transplant candidates and better pre-operative preparation might lower this post-operative risk. Besides, post-transplant anaemia should be prevented.
No takes yet. Share an insight, caveat, or question.
Dekker et al. (2020) conducted a cohort in End-stage renal disease undergoing kidney transplantation (n=770). Positive non-invasive ischaemia testing vs. Negative or no non-invasive ischaemia testing was evaluated on Composite of cardiac death, myocardial infarction, coronary revascularisation or admission for heart failure within 3 months after transplantation (RR 2.6, 95% CI 1.4-5.1, p=0.01). Positive pre-operative non-invasive ischaemia testing was significantly associated with an increased risk of cardiovascular events within 3 months after kidney transplantation (RR 2.6).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: